Background:
Benign
prostate
hyperplasia
(BPH)
was
one
of
the
major
chronic
complications
type
2
diabetes
mellitus
(T2DM),
and
sex
steroid
hormones
were
common
risk
factors
for
occurrence
T2DM
BPH.Methods:
The
profiles
simultaneous
quantified
by
LC-MS/MS
in
clinical
serum
patients,
including
simple
BPH,
new
diagnosed
T2DM,
complicated
with
BPH
matched
healthy
subjects.
Clinical
tissues,
G
protein-coupled
estrogen
receptor
(GPER)
inhibitor
G15,
GPER
knockdown
lentivirus,
YAP1
Verteporfin,
knockdown/overexpression
targeted
metabolomics
analysis,
Co-IP
assays
used
to
investigate
molecular
mechanisms
dysregulated
pathological
process
BPH.Findings:
Along
prostatic
epithelial
cells
(PECs)
proliferation,
patients.
Sex
hormone
metabolic
patients
had
greatest
degree
separation
from
that
As
contributor
hormones,
elevated
17β-estradiol
(E2)
a
significant
positive
relationship
characteristics
BPH.
E2
through
activating
exacerbated
high
glucose
(HG)-induced
PECs
proliferation
formation
YAP1-TEAD4
heterodimer
via
Hippo
signaling.
Knockdown
or
inhibition
GPER-mediated
Hippo-YAP1
signaling
suppressed
HG
co-cultured
BPH-1
cells.
anti-proliferative
effects
verteporfin,
an
YAP1,
blocked
overexpression
cells.Interpretation:
Inactivating
E2/GPER/Hippo/YAP1
might
be
effective
delaying
progression
inhibiting
proliferation.Clinical
Trial
Registration
Details:
This
study
registered
Chinese
Register
(No.
ChiCTR1800020339).Funding
Information:
work
supported
National
Natural
Science
Foundation
China
(81973377,
81903689,
82073906
82273987),
Key
Jiangsu
Higher
Education
Institutions
(19KJA460008
19KJB350006),
Priority
Academic
Program
Development
(PAPD),
initializing
Fund
Xuzhou
Medical
University
(D2018011),
Postgraduate
Research
Practice
Innovation
Province
(KYCX22-2966
KYCX23-2967).
Declaration
Interests:
authors
declare
no
competing
interests.
Ethics
Approval
Statement:
All
procedures
studies
performed
according
Helsinki.
approved
Committee
Affiliated
Hospital
XYFY2018-KL093).
BMC Cancer,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: Feb. 19, 2025
Bladder
cancer
(BLCA)
is
notably
associated
with
advanced
age,
characterized
by
its
high
incidence
and
mortality
among
the
elderly.
Despite
promising
advancements
in
models
that
amalgamate
molecular
subtypes
treatment
prognostic
outcomes,
considerable
heterogeneity
BLCA
poses
challenges
to
their
universal
applicability.
Consequently,
there
an
urgent
need
develop
a
new
subtyping
system
focusing
on
critical
clinical
feature
of
BLCA:
senescence.
Utilizing
unsupervised
clustering
Cancer
Genome
Atlas
Program
(TCGA)-BLCA
cohort,
we
crafted
senescence-associated
classification
precision
quantification
(Senescore).
This
method
underwent
systematic
validation
against
established
subtypes,
strategies,
immune
tumor
microenvironment
(TME),
relevance
checkpoints,
identification
potential
therapeutic
targets.
External
validations
were
conducted
using
Xiangya
IMvigor210
meta-cohort,
multiplex
immunofluorescence
confirming
correlation
between
Senescore,
infiltration,
cellular
Notably,
patients
categorized
within
higher
Senescore
group
predisposed
basal
subtype,
showcased
augmented
harbored
elevated
driver
gene
mutations,
exhibited
increased
secretory
phenotype
(SASP)
factors
expression
transcriptome.
poorer
prognoses,
these
revealed
greater
responsiveness
immunotherapy
neoadjuvant
chemotherapy.
Our
informed
age-related
features,
accurately
depict
age-associated
biological
traits
application
BLCA.
Moreover,
this
personalized
assessment
framework
poised
identify
senolysis
targets
unique
BLCA,
furthering
integration
aging
research
into
strategies.
Redox Report,
Journal Year:
2024,
Volume and Issue:
29(1)
Published: Aug. 5, 2024
Backgroud
Bronchopulmonary
dysplasia
(BPD)
is
one
of
the
most
important
complications
plaguing
neonates
and
can
lead
to
a
variety
sequelae.
ability
HIF-1α/VEGF
signaling
pathway
promote
angiogenesis
has
an
role
in
neonatal
lung
development.
International Journal of Medical Sciences,
Journal Year:
2025,
Volume and Issue:
22(5), P. 1138 - 1149
Published: Feb. 10, 2025
Background:
Rat
models
are
widely
used
to
study
cataracts
due
their
cost-effectiveness
and
prominent
physiological
genetic
similarities
humans
The
objective
of
this
was
identify
genes
involved
in
cataractogenesis
galactose
exposure
rats.
Methods:
We
analyzed
four
datasets
from
the
Gene
Expression
Omnibus,
including
both
ex
vivo
different
rat
strains.
Feature
selection
tools
were
potentially
relevant
cataract-related
gene
expression.
A
decision
tree
algorithm
implemented,
its
predictions
interpreted
using
SHAP
LIME.
To
validate
expression
levels,
PCR
conducted
on
six
lenses
cultured
M199
medium
induce
cataract
alone.
Results:
Using
feature
tools,
key
genes-PLAGL2,
CMTM7,
PCYT1B,
NR1D2-were
identified.
Only
PCYT1B
significantly
differentially
expressed
between
control
groups
across
datasets.
model
showed
strong
predictive
performance,
particularly
LIME
analyses
revealed
that
CMTM7
had
largest
impact
predictions.
results
did
not
show
significant
differences
groups.
Conclusion:
trained
an
dataset
could
predict
despite
no
found
Given
a
small
number
samples,
larger
studies
needed
our
findings.
IUBMB Life,
Journal Year:
2025,
Volume and Issue:
77(3)
Published: March 1, 2025
Abstract
Laryngeal
squamous
cell
carcinoma
(LSCC)
exhibits
aggressive
growth,
frequent
recurrence,
and
a
notable
resistance
to
existing
treatments.
Building
upon
prior
discoveries
that
identified
junctional
adhesion
molecule
3
(JAM3)
as
critical
tumor
suppressor
in
LSCC,
this
study
delves
into
the
transcriptional
regulation
by
upstream
stimulatory
factor
1
(USF1)
its
implications
for
LSCC
pathogenesis.
Employing
dual‐luciferase
assays
chromatin
immunoprecipitation–quantitative
polymerase
chain
reaction
(ChIP‐qPCR),
we
confirmed
USF1's
direct
binding
E‐box
within
JAM3
promoter,
thereby
enhancing
expression
AMC‐HN‐8
FD‐LSC‐1
cells.
Complementary
vitro
vivo
experiments
corroborated
USF1
overexpression
markedly
reduces
aggressiveness,
linked
heightened
activity.
Further
analysis,
including
Western
blot
immunohistochemistry
of
xenograft
tissues,
revealed
increased
JAM3,
stimulated
USF1,
activates
Hippo
signaling
pathway,
underscoring
role
suppression.
These
findings
position
pivotal
elements
molecular
framework
suggesting
their
potential
targets
therapeutic
intervention.
Cell Communication and Signaling,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: June 19, 2024
Abstract
Background
Endocrine
resistance
driven
by
sustained
activation
of
androgen
receptor
(AR)
signaling
pathway
in
advanced
prostate
cancer
(PCa)
is
fatal.
Characterization
mechanisms
underlying
aberrant
AR
to
search
for
potential
therapeutic
strategy
particularly
important.
Rac
GTPase-activating
protein
1
(RACGAP1)
one
the
specific
proteins.
As
a
novel
tumor
proto-oncogene,
overexpression
RACGAP1
was
related
occurrence
various
tumors.
Methods
Bioinformatics
methods
were
used
analyze
relationship
expression
level
between
and
as
well
activation.
qRT-PCR
western
blotting
assays
performed
assess
AR/AR-V7
PCa
cells.
Immunoprecipitation
immunofluorescence
experiments
conducted
detect
interaction
co-localization
AR/AR-V7.
Gain-
loss-of-function
analyses
investigate
biological
roles
cells,
using
MTS
colony
formation
assays.
In
vivo
evaluate
effect
inhibition
on
growth.
Results
gene
activated
AR,
which
markedly
upregulated
patients
with
CRPC
enzalutamide
resistance.
transcriptionally
binding
its
promoter
region.
Reciprocally,
nuclear
bound
N-terminal
domain
(NTD)
both
AR-V7,
blocking
their
E3
ubiquitin
ligase
MDM2.
Consequently,
this
prevented
degradation
ubiquitin-proteasome-dependent
pathway.
Notably,
positive
feedback
loop
contributed
endocrine
therapy
CRPC.
Combination
cholesterol-conjugated
RIG-I
siRNA
drugs
targeting
induced
potent
xenograft
growth
PCa.
Conclusion
summary,
our
results
reveal
that
reciprocal
regulation
contributes
These
findings
highlight
combined
treatment
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 19, 2024
Background
Statins,
which
are
medications
that
lower
lipid
levels,
extensively
used
to
decrease
cardiovascular
disease
risk.
Recently,
the
use
of
statins
in
cancer
prevention
has
attracted
considerable
interest.
However,
it
is
still
unclear
whether
a
causal
effect
on
bladder
cancer.
Methods
The
two-sample
Mendelian
Randomization
(MR)
was
performed
infer
relationship
between
statin
therapy
(atorvastatin,
simvastatin,
and
rosuvastatin)
Single-nucleotide
polymorphisms
(SNP)-based
genome-wide
association
studies
(GWAS)
were
gathered
from
UK
Biobank,
involving
462,933
participants.
We
acquired
summary-level
genetic
data
European
cohort
175,121
individuals.
inverse
variance
weighted
(IVW)
method
main
analytical
technique
used,
supplemented
by
MR-Egger,
median,
mode,
simple
mode
estimate
effects.
Additionally,
sensitivity
analyses
conducted
verify
robustness
reliability
our
findings.
Results
Based
IVW
analysis,
we
identified
significant
rosuvastatin
decreased
risk
cancer,
with
analysis
inferring
substantial
reduction
odds
(OR
=
3.52E-19,
95%
CI:
5.48E-32–2.26E-06,
p
0.005).
In
contrast,
results
did
not
reveal
statistically
genetically
estimated
atorvastatin
7.42E-03,
6.80E-06–8.084,
0.169)
or
simvastatin
0.135,
0.008–2.330,
0.168)
Conclusion
investigated
link
using
among
population.
Our
findings
indicated
predicted
associated
whereas
no
effects
observed
for
use.